Years of Know-
How Advancing
Bacterial Therapeutics

Our Services

List Labs is a microbial CDMO with over 45 years of experience manufacturing bacterial-derived products for the microbiome therapeutics and biopharmaceutical markets. Founded in 1978, List Labs was one of the first CDMOs to manufacture a clinical-phase live biotherapeutic product (LBP) and today operates a purpose-built, 26,000 sq ft clinical-scale facility in Campbell, CA. Unlike generalist microbial CDMOs built around E. coli and yeast recombinant protein platforms. List labs has completed projects with over 60 different species of bacteria demonstrating a greater depth of microbial knowledge than any other CDMO, offering full-range CDMO services from early-stage process development through cGMP manufacturing for Phase I and II clinical supply, with drug substance and drug product production under one roof.

Start Your Project Today

We offer a full range of
CDMO services from early-stage

We offer a full range of services from early-stage process development to cGMP manufacturing for Phase I & II clinical supply, meeting the needs of pharmaceutical companies, biotechs, start-ups, and government organizations. Our expertise includes development and manufacturing of bacterial derived products from purified polysaccharides and proteins to live bacteria.

We are also currently planning our expansion to add Phase III and commercial manufacturing at a new facility, which will enhance our fully integrated CDMO offering.

Live Biotherapeutics

Bacterial
Toxins

Bacterial Polysaccharides

Recombinant Proteins

Custom
Services

Great stories
from great customers

“We are pleased to be partnering with List Labs in the manufacturing of our proprietary interferon alpha 2b. We believe our novel engineered interferon alpha 2b derived from our proprietary master cell bank offers important advantages that allows for a quick scale up of manufacturing, especially in terms of logistics and cost of goods,..

Dr. Doroudian, Altum Pharma

“List labs staff are scientifically sound and very responsive to needs during difficult times, especially during GMP manufacturing.”

Microbiome Therapeutic Company in Phase I Clinical Trials

“Microbiome-based drugs, designated live biotherapeutic products by FDA, are quite different from other biologics because the bacterium itself is the drug. Few CDMOs in the US have the expertise to manufacture LBPs, so we were fortunate to find List Biological Laboratories in Campbell, CA to produce our LBP for Phase 2 clinical trials. List Labs successfully produced both drug substance and a complex drug product under one roof, which saved us considerable time and money. We would recommend List Labs to companies with innovative products who are looking for a manufacturer of early stage clinical products.”

Microbiome Therapeutic Company in Phase II Clinical Trials

“List Labs has consistently provided us with the highest level of service and quality for development and cGMP manufacturing of our live biotherapeutic product for Phase I clinical trials, while remaining sensitive to our cost requirements and timelines.  I would strongly recommend them for any future project.”

Scioto Biosciences

“We have been using your PT and FHA antigens for decades, and LOVE them!”

Harry Prince, Scientific Director for Immunology, Focus Diagnostics

Dr. Doroudian, Altum Pharma

“List labs staff are scientifically sound and very responsive to needs during difficult times, especially during GMP manufacturing.”

Microbiome Therapeutic Company in Phase I Clinical Trials

Microbiome Therapeutic Company in Phase II Clinical Trials

Scioto Biosciences

“We have been using your PT and FHA antigens for decades, and LOVE them!”

Harry Prince, Scientific Director for Immunology, Focus Diagnostics

What is microbial CDMO?

A microbial CDMO (contract development and manufacturing organization) develops and manufactures microbial derived drug substances using bacterial or yeast expression systems, rather than mammalian cell lines. This includes process development, cGMP manufacturing, and analytical testing for products like recombinant proteins, live biotherapeutics, toxins, and polysaccharides.

How do I choose a microbial CDMO partner?

Key factors: host organism/platform experience relevant to your molecule, track record with your specific modality (e.g., LBPs vs. recombinant proteins vs. toxins), integrated drug substance/drug product capability, cGMP facility scale, and clinical-phase experience (Phase I/II vs. commercial).

Does List Labs manufacture live biotherapeutic products (LBPs)?

Yes. List Labs is one of a small number of CDMOs with dedicated experience manufacturing live biotherapeutic products, including drug substance and complex drug product production under one roof for Phase I and II clinical trials.

Years of Know- How Advancing Bacterial Therapeutics